BAG1 is Neuroprotective in In Vivo and In Vitro Models of Parkinson’s Disease

Disruption of Protein Quality Control in Parkinson's Disease

(2013) C. Cook et al.   Cold Spring Harbor Perspectives in Medicine

BAG1 restores formation of functional DJ-1 L166P dimers and DJ-1 chaperone activity

(2010) Sebastian Deeg et al.   JOURNAL OF CELL BIOLOGY

Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3

(2009) Martin Gamerdinger et al.   EMBO JOURNAL

BAG1 modulates huntingtin toxicity, aggregation, degradation, and subcellular distribution

(2009) Kamila Sroka et al.   JOURNAL OF NEUROCHEMISTRY

Abberant α-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy

(2009) Maria Xilouri et al.   PLoS One

BAG1 promotes axonal outgrowth and regeneration in vivo via Raf-1 and reduction of ROCK activity

(2008) Véronique Planchamp et al.   BRAIN

Accumulation and clearance of -synuclein aggregates demonstrated by time-lapse imaging

(2008) Felipe Opazo et al.   JOURNAL OF NEUROCHEMISTRY

Aggregopathy in Neurodegenerative Diseases: Mechanisms and Therapeutic Implication

(2008) C.P. Dohm et al.   Neurodegenerative Diseases

Formation of Toxic Oligomeric α-Synuclein Species in Living Cells

(2008) Tiago Fleming Outeiro et al.   PLoS One